AMRX•benzinga•
JP Morgan Upgrades Amneal Pharmaceuticals to Overweight, Raises Price Target to $12
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 24, 2025 by benzinga